Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
Go back to Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 0.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $0.04 | |||
| Open | $0.90 | 52 Week Low | $0.00 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $0.00 | |||
| Volume | 8,059 | |||||
